Part 1. Basic science and pathophysiology 1. Obesity and insulin resistance 2. Diabetes and macrovascular disease: epidemiology and cardiovascular risk assessment 3. Hypertension 4. Lipid metabolism: role in atherogenesis 5. Renal disease and cardiorenal interactions 6. NAFLD/NASH and cardiovascular risk 7. Heart failure 8. Prothrombosis: association with cardiometabolic disease 9. Inflammation, metabolism and cardiovascular disease 10. Classic endocrine disorders: association with vascular disease
Part 2. Clinical evaluation, lifestyle measures and therapeutic options 11. Non-pharmacological strategies in the prevention and management of cardiometabolic disease 12. Obesity: pharmacological approaches to prevention and management 13. Diabetes: evolution of multifactorial vascular risk reduction 14. Diabetes CVOTS: design, interpretation and future directions 15. Novel glucose-lowering drugs: a new era of cardioprotection and renoprotection 16: Hypertension: pharmacological and surgical management 17. PCSK-9 inhibitors and other novel lipid-modifying drugs 18. Recent therapeutic developments in heart failure 19. Antiplatelet agents 20. Progress in anticoagulant therapy 21. Invasive treatment of atherosclerotic cardiovascular disease: today and tomorrow 22. Cardiometabolic medicine in practice: role of cardiologists vs endocrinologists and the need for a new clinical specialty